Bartter's/Gitelman's syndrome: A model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling [2]

Clinical Nephrology

Volumn 59, Issue 5, 2003, Pages 393-394

  Calo L A ^a   Davis, P A ^b   Semplicini, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; LOW DENSITY LIPOPROTEIN; NITROUS OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANGIOGENESIS; BARTTER SYNDROME; BLOOD VESSEL REACTIVITY; DISEASE ASSOCIATION; DISEASE MODEL; GITELMAN SYNDROME; HEMOSTASIS; HUMAN; HYPERTENSION; LETTER; LIPID OXIDATION; OXIDATIVE STRESS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0038057542     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp59393     Document Type: Letter

References (12)

1. Calò L, Cantaro S, Calabrò A, Piarulli F, Rizzolo M, Favaro S, Antonello A, Crepaldi G, Borsatti A 1995 Endothelium-derived vasoactive substances in Bartter's syndrome. Angiology 46: 905-913
2. Calò D, D'Angelo A, Cantaro S, Rizzolo M, Favaro S, Antonello A, Borsatti A 1996a Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. Nephron 72: 570-573
3. - and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis 27: 784-789
4. Calò L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D'Angelo A, Davis PA, Manzato E, Crepaldi G 1998 Reduced susceptibility of low-density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 16: 1001-1008
5. Calò L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S, D'Angelo A 1999 Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 51: 12-17
6. Calò L, Davis PA, Semplicini A 2000 Control of vascular tone in the syndromes of Bartter and Gitelman. Crit Rev Clin Lab Sci 37: 503-522
7. Calò L, Ceolotto G, Milani MM, Pagnin E, van den Heuvel LP, Sartori M, Davis PA, Costa R, Semplicini A 2001a Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int 60: 882-889
8. Calò L, Pagnin E, Sartori M, Vianello D, Davis PA, Zaghetto F, Ceolotto G, Semplicini A 2001b Redox signaling and its relationship with vascular hyporeactivity in Bartter's and Gitelman's syndrome (BS/GS). JASN 12: 587
9. Calò L, Pagnin E, Davis PA, Sartori M, Semplicini A 2003 Oxidative stress related factors in Bartter's and Gittelman's syndromes: relevance for angiotensin II signaling. Nephrol Dial Transpl, in press
10. Di Virgilio F, Calò L, Cantaro S, Favaro S, Piccoli A, Borsatti A 1987 Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Clin Sci 72: 483-488
11. Dzau VJ 2001 Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 37: 1047-1052
12. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW 1997 Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29: 366-337